Lind, Marcus <br/><br/>
Cystatin C and creatinine as markers of bleeding complications, cardiovascular events and mortality during oral anticoagulant treatment.  [electronic resource] 

 -  Thrombosis research  Aug 2013 
 - e77-82 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1879-2472 
<br/><br/><label>Standard No.: </label>10.1016/j.thromres.2013.06.011  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Aged<br/>Anticoagulants--administration & dosage<br/>Biomarkers--blood<br/>Cardiovascular Diseases--blood<br/>Cohort Studies<br/>Creatinine--blood<br/>Cystatin C--blood<br/>Female<br/>Hemorrhage--blood<br/>Humans<br/>Longitudinal Studies<br/>Male<br/>Prognosis<br/>Risk Factors<br/>Sweden--epidemiology